FDA inspection
Aventis Pharma Manufacturing Pte. Ltd.: FDA inspection ending Nov 8, 2002
FDA inspection 260240 · Voluntary Action Indicated (VAI) · Singapore
Key facts
| Inspection ID | 260240 |
|---|---|
| Firm | Aventis Pharma Manufacturing Pte. Ltd. |
| FEI number | 3003091951 |
| Address | 61 Gul Circle |
| City | Singapore |
| Fiscal year | 2003 |
| Inspection end date | Nov 8, 2002 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data